No Detail Found!

Expression of Snail and E-cadherin in Drug-resistant MCF-7/ADM Breast Cancer Cell Strains.

Author(s)
Fenglin Cai Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital, and Jiangsu Institute of Cancer Research, 210009, China; Department of General Surgery, Northern Jiangsu People's Hospital, 225001, China
Hualin Xiao Department of General Surgery, Northern Jiangsu People's Hospital, 225001, China
Yuting Sun Department of General Surgery, Northern Jiangsu People's Hospital, 225001, China
Dongfeng Wang Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital, and Jiangsu Institute of Cancer Research, 210009, China
Jinhai Tang Department of General Surgery, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
Abstract
Objective: To investigate the expression of zinc finger transcription factors-Snail and E-cadherin in adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Study Design: An experimental study. Place and Duration of Study: The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital, and Jiangsu Institute of Cancer Research, China, from April 2017 to March 2018. Methodology: Real-time quantitative PCR technology was used to detect the expression levels of Snail mRNA and E-cadherin mRNA in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Western blot was used to detect the expression levels of proteins of Snail and E-cadherin in normal breast cells, adriamycin-resistant human breast cancer MCF-7/ADM cells and non-resistant MCF-7 cells. Results: The expression of Snail mRNA and protein in adriamycin-resistant human breast cancer MCF-7/ADM cells was significantly higher than that in normal breast cells (p<0.001) and non-resistant MCF-7 cells (p<0.001). The expression of E-cadherin mRNA and protein in adriamycin-resistant human breast cancer MCF-7/ADM cells was significantly lower than that in normal breast cells (p<0.001) and non-resistant MCF-7 cells (p<0.001). Conclusion: Adriamycin-resistant human breast cancer MCF-7/ADM cell strains had high expression of Snail and low expression of E-cadherin. This points out to a new research direction for the targeted therapy of drug-resistant breast cancer cells, and provides clinical guidance for breast cancer therapy and prognosis evaluation.
Publication Details
Page(s) 240-244
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 3, Year: 2019

Request the full text from PASTIC

References
LiX,LewisMT,HuangJ,GutierrezC,OsborneCK,WuMF, 2008.Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy,J Nati Cancer Inst 100 672 -9
GoswamiS,WangW,WyckoffJB,CondeelisJS, 2004.Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy,Cancer Res 64 7664 -7
SteinerR,StewartJF,CantwellBM,MintonMJ,KnightRK,RubensRD, 1983.Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer,Eur J Cancer Clin Oncol 19 1553 -7
MaF,ZhangJ,ZhongL,WangL,LiuY,WangY, 2013.Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/-catenin signaling,Gene 535 191 -7
LeeJM,DedharS,KalluriR,ThompsonEW, 2006.The epithelialmesenchymal transition: new insights in signaling, development, and disease,J Cell Biol 172 973 -81
PeinadoH,OlmedaD,CanoA, 2007.Snail, ZEB and BHLH factors in tumour progression: an alliance against the epithelial phenotype,Nat Rev Cancer 7 415 -28
Chavez-MacGregorM,Gonzalez-AnguloAM, 2013.Breast cancer in 2012: New drugs, new knowledge, new targets,Nat Rev Clin Oncol 10 75 -6
ZardavasD,BaselgaJ,PiccartM., 2013.Emerging targeted agents in metastatic breast cancer,Nat Rev Clin Oncol 10 191 -210
ShenH,WangD,LiL,YangS,ChenX,ZhouS, 2016.-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway,Gene 596 110 -8
NooterK,StoterG, 1996.Molecular mechanisms of multidrug resistance in cancer chemotherapy,Pathol Res Pract 192 768 -80
BurgerH,FoekensJA,LookMP,MeijervanMG,KlijnJG,WiemerEA, 2003.RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistanceassociated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response,Clin Cancer Res 9 827 -36
ColeyHM, 2008.Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer,Cancer Treat Rev 34 378 -90
MccubreyJA,AbramsSL,FitzgeraldTL,CoccoL,MartelliAM,MontaltoG, 2015.Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis,Adv Biol Regul 57 75 -101
de HerrerosAG,PeiróS,NassourM,SavagnerP, 2010.Snail family regulation and epithelial mesenchymal transitions in breast cancer progression,J Mammary Gland Biol Neoplasia 15 135 -47
ZhangA,WangQ,HanZ,WeiHU,LingXI,GaoQ, 2013.Reduced expression of snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPase,Oncol Lett 6 339 -46
TsubakiM,KomaiM,FujimotoSI,ItohT,ImanoM,SakamotoK, 2013.Activation of NF-B by the RANKL/RANK system upregulates snail and twist expressions and induces epithelial-tomesenchymal transition in mammary tumor cell lines,J Exp Clin Cancer Res 32 62 -
BrabantG,Hoang-VuC,CetinY,DralleH,ScheumannG,MölneJ, 1993.E-cadherin: a differentiation marker in thyroid malignancies,Cancer Res 53 4987 -93
KremerM,Quintanilla-MartinezL,FuchsM,GamboaDominguezA,HayeS,KalthoffH, 2003.Influence of tumorassociated e-cadherin mutations on tumorigenicity and metastasis,Carcinogenesis 24 1879 -86
MatsumotoK,ShariatSF,CasellaR,WheelerTM,SlawinKM,LernerSP, 2003.Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy,J Urol 170 2248 -52
ZhuoWL,WangY,ZhuoXL,ZhangYS,ChenZT, 2008.Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/ mitochondrial pathway,Biochem Biophys Res Commun 369 1098 -102
0

Citations

0

Downloads

69

Views